Cancer Gastrointestinal (Stomach) Cancer

Table of Contents

Gastrointestinal (Stomach) Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Gastrointestinal (Stomach) Cancer Projects
--AstraZeneca Plc
--Amgen Inc
--Chugai Pharmaceutical Co Ltd
--BTG plc
--Fresenius AG
--Eli Lilly & Co
--GlaxoSmithKline plc
--Genta Incorporated
--Merck KGaA
--ImmunoGen Inc
--Pfizer Inc
--Novartis AG
--Receptor BioLogix, Inc.
--Pierre Fabre Medicament
--SuperGen Inc
--Roche Holdings Ltd
--TRION Pharma GmbH
--Taiho Pharmaceutical Co., Ltd.
--Yakult Honsha Co., Ltd.
--Wellstat Therapeutics Corporation

--Top Companies in early stage Gastrointestinal (Stomach) Cancer Projects
--BT PHARMA
--AstraZeneca Plc
--Infinity Pharmaceuticals Inc
--Eisai Co Ltd
--Oncothyreon, Inc.
--MEABCO A/S
--Regulon, Inc
--Patrys Limited
--United Therapeutics Corporation
--Takeda Pharmaceutical Company Limited
--ViRexx Medical Corp
--VGX Pharmaceuticals, Inc

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View